dc.contributor.author | Asli, Kurne | |
dc.contributor.author | Guliz, Sayat | |
dc.contributor.author | Cansin, Sackesen | |
dc.contributor.author | Esra, Birben | |
dc.contributor.author | faruk, Aydin Omer | |
dc.contributor.author | Murat, Terzi | |
dc.contributor.author | Rana, Karabudak | |
dc.date.accessioned | 2020-06-21T14:46:44Z | |
dc.date.available | 2020-06-21T14:46:44Z | |
dc.date.issued | 2010 | |
dc.identifier.issn | 0165-5728 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/17650 | |
dc.description | 10th Congress of the International-Society-of-Neuroimmunology (ISNI) -- OCT 26-30, 2010 -- Sitges, SPAIN | en_US |
dc.description | WOS: 000283694400079 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | Int Soc Neuroimmunol | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Do polymorphisms at the CD14 promotor gene and soluble CD14 levels effect biological response to IFN beta therapy in multiple sclerosis? | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 228 | en_US |
dc.identifier.issue | 01.Feb | en_US |
dc.identifier.startpage | 28 | en_US |
dc.identifier.endpage | 28 | en_US |
dc.relation.journal | Journal of Neuroimmunology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |